Boston Scientific v. J&J
This article was originally published in The Gray Sheet
Executive Summary
U.S. District Court in Delaware awards Boston Scientific and its stent supplier Medinol $8.3 mil. in damages after finding Johnson & Johnson's Corinthian stent infringes a valid Medinol patent claim, Boston Scientific announced Sept. 7. The jury also found that J&J's Bx Velocity, Crown and Mini Crown stents do not infringe patents owned by Medinol; the complaint was filed in April 2000 (1"The Gray Sheet" May 1, 2000, p. 15). Boston Scientific plans to appeal the mixed verdict if the judge will not agree to set aside the jury's decision
You may also be interested in...
Boston Scientific Stent Suit Seeks Injunctive Relief From J&J Market Entry
Boston Scientific's stent patent suit against Johnson & Johnson's Cordis unit follows by ten days an agreement between J&J and Guidant to co-develop balloon dilatation catheters on a rapid-exchange platform.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.